Circulating XO can bind with sulfated glycosaminoglycans on the surface of endothelial cells by competing for the binding sites of heparin [26], thus promoting endothelial activation during pro-oxidant and pro-inflammatory states, and consequently contributing to endothelial dysfunction [27,28]. The gene discussed is XDH; the disease is endothelial dysfunction.